Nasopharynx Cancer: Therapeutic Value of Chemoradiotherapy

International Journal of Radiation Oncology Biology Physics

Volumn 69, Issue 2 SUPPL., 2007, Pages

  O'Sullivan, Brian ^a  

^a UNIVERSITY OF TORONTO   (Canada)

Author keywords

Chemotherapy; Meta analysis; Nasopharyngeal carcinoma; Radiotherapy; Survival

Indexed keywords

CHEMOTHERAPY; DATA REDUCTION; DISEASES; HISTOLOGY; RADIOTHERAPY; TUMORS;

LYMPH NODES; META-ANALYSIS; NASOPHARYNGEAL CARCINOMA; SURVIVAL;

ONCOLOGY;

CISPLATIN; FLUOROURACIL;

ARTICLE; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER RELAPSE; CANCER STAGING; CANCER SURVIVAL; DEATH; DIAGNOSTIC IMAGING; ENDEMIC DISEASE; HISTOLOGY; HUMAN; LYMPH NODE; LYMPH NODE METASTASIS; MEDICAL LITERATURE; METASTASIS; NASOPHARYNX CANCER; OUTCOME ASSESSMENT; PRIORITY JOURNAL; TREATMENT RESPONSE; TUMOR DIFFERENTIATION;

COMBINED MODALITY THERAPY; HUMANS; NASOPHARYNGEAL NEOPLASMS; RANDOMIZED CONTROLLED TRIALS AS TOPIC;

EID: 34548426154     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2007.04.085     Document Type: Article

References (10)

1. Wei W.I., and Sham J.S. Nasopharyngeal carcinoma. Lancet 365 (2005) 2041-2054
2. Baujat B., Audry H., Bourhis J., et al. Chemotherapy in locally advanced nasopharyngeal carcinoma: An individual patient data meta-analysis of eight randomized trials and 1753 patients. Int J Radiat Oncol Biol Phys 64 (2006) 47-56
3. Al-Sarraf M., LeBlanc M., Giri P.G., et al. Superiority of 5-year survival with chemoradiotherapy vs radiotherapy in patients with locally advanced nasopharyngeal cancer. Intergroup 0099 Phase III study: Final report. [Abstract]. Proc Am Soc Clin Oncol 20 (2001) 227a
4. Wee J., Tan E.H., Tai B.C., et al. Final report of SQNP01-a phase III randomized trial comparing RT with chemoRT for locally advanced nasopharyngeal cancer. [Abstract]. Int J Radiat Oncol Biol Phys 66 3 Suppl. (2006) S16
5. Lee A.W., Lau W.H., Tung S.Y., et al. Preliminary results of a randomized study on therapeutic gain by concurrent chemotherapy for regionally-advanced nasopharyngeal carcinoma: NPC-9901 Trial by the Hong Kong Nasopharyngeal Cancer Study Group. J Clin Oncol 23 (2005) 6966-6975
6. Lee A.W., Tung S.Y., Chan A.T., et al. Preliminary results of a randomized study (NPC-9902 Trial) on therapeutic gain by concurrent chemotherapy and/or accelerated fractionation for locally advanced nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys 66 (2006) 142-151
7. Chan A.T., Leung S.F., Ngan R.K., et al. Overall survival after concurrent cisplatin-radiotherapy compared with radiotherapy alone in locoregionally advanced nasopharyngeal carcinoma. J Natl Cancer Inst 97 (2005) 536-539
8. Kwong D.L., Sham J.S., Au G.K., et al. Concurrent and adjuvant chemotherapy for nasopharyngeal carcinoma: a factorial study. J Clin Oncol 22 (2004) 2643-2653
9. Lin J.C., Jan J.S., Hsu C.Y., et al. Phase III study of concurrent chemoradiotherapy versus radiotherapy alone for advanced nasopharyngeal carcinoma: Positive effect on overall and progression-free survival. J Clin Oncol 21 (2003) 631-637
10. Zhang L., Zhao C., Peng P.J., et al. Phase III study comparing standard radiotherapy with or without weekly oxaliplatin in treatment of locoregionally advanced nasopharyngeal carcinoma: Preliminary results. J Clin Oncol 23 (2005) 8461-8468